JOSE LUIS
LABANDEIRA GARCIA
Catedrático de universidad
![Foto de JOSE LUIS](/img/nophoto.png)
![Foto de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas](/img/noimage_org.png)
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (96)
2024
-
Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission
npj Parkinson's Disease, Vol. 10, Núm. 1
-
Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance
Molecular Metabolism, Vol. 79
-
Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain
Neuropathology and Applied Neurobiology, Vol. 50, Núm. 1
-
Ionizable nanoemulsions for RNA delivery into the central nervous system – importance of diffusivity
Journal of Controlled Release, Vol. 372, pp. 295-303
-
Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson’s disease models
Stem Cell Research and Therapy, Vol. 15, Núm. 1
-
The role of the brain renin-angiotensin system in Parkinson´s disease
Translational Neurodegeneration, Vol. 13, Núm. 1
2023
-
A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease
Parkinsonism and Related Disorders, Vol. 110
-
AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability
Brain, Behavior, and Immunity, Vol. 108, pp. 255-268
-
Astrocytic insulin receptor controls circadian behavior via dopamine signaling in a sexually dimorphic manner
Nature Communications, Vol. 14, Núm. 1
-
Boolean analysis shows a high proportion of dopamine D2 receptors interacting with adenosine A2A receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease
Neurobiology of Disease, Vol. 188
-
Combined cell-based therapy strategies for the treatment of Parkinson's disease: Focus on mesenchymal stromal cells
Neural Regeneration Research, Vol. 18, Núm. 3, pp. 478-484
-
Extracellular Vesicles and Their Renin–Angiotensin Cargo as a Link between Metabolic Syndrome and Parkinson’s Disease
Antioxidants, Vol. 12, Núm. 12
-
Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia
Antioxidants, Vol. 12, Núm. 7
-
Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates
Brain : a journal of neurology, Vol. 146, Núm. 12, pp. 5000-5014
-
The cannabinoid CB1 receptor interacts with the angiotensin AT2 receptor. Overexpression of AT2-CB1 receptor heteromers in the striatum of 6-hydroxydopamine hemilesioned rats
Experimental Neurology, Vol. 362
2022
-
Angiotensin System Autoantibodies Correlate With Routine Prognostic Indicators for COVID-19 Severity
Frontiers in Medicine, Vol. 9
-
Angiotensin Type-1 Receptor Inhibition Reduces NLRP3 Inflammasome Upregulation Induced by Aging and Neurodegeneration in the Substantia Nigra of Male Rodents and Primary Mesencephalic Cultures
Antioxidants, Vol. 11, Núm. 2
-
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
npj Parkinson's Disease, Vol. 8, Núm. 1
-
Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment
Biomedicines, Vol. 10, Núm. 2
-
Inflammatory Role of Milk Fat Globule– Epidermal Growth Factor VIII in Age-Associated Arterial Remodeling
Journal of the American Heart Association, Vol. 11, Núm. 17